Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)

被引：0
|
作者：
Lipton, JH
Gospodarowicz, M
Reingold, S
机构：
[1] PRINCESS MARGARET HOSP,ONTARIO CANC INST,DEPT MED,TORONTO,ON M4X 1K9,CANADA
[2] PRINCESS MARGARET HOSP,ONTARIO CANC INST,DEPT RADIAT ONCOL,TORONTO,ON M4X 1K9,CANADA
[3] UNIV TORONTO,TORONTO,ON,CANADA
[4] PEEL MEM HOSP,DEPT MED,BRAMPTON,ON,CANADA
来源：
HEMATOLOGICAL ONCOLOGY | 1996年 / 14卷 / 01期
关键词：
acute myeloid leukemia; Hodgkin's disease; ABVD; radiation therapy; secondary leukemia;
D O I：
10.1002/(SICI)1099-1069(199603)14:1<29::AID-HON561>3.0.CO;2-J
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A 26-year-old man developed myelodysplasia rapidly progressing to acute myelomonocytic leukemia 3 years after receiving three cycles of ABVD chemotherapy and upper mantle and upper abdomen radiotherapy for stage IA Hodgkin's disease. This represents the fourth such case reported. The risk of secondary AML after ABVD or radiation therapy is discussed.
引用
收藏
页码：29 / 31
页数：3
相关论文
共 50 条
  • [21] Phase 3 study of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A plus AVD) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) as front-line treatment for advanced classical Hodgkin lymphoma (HL): Echelon-1 study
    Ansell, Stephen Maxted
    Younes, Anas
    Connors, Joseph M.
    Gallamini, Andrea
    Kim, Won Seog
    Friedberg, Jonathan W.
    Feldman, Tatyana A.
    Collins, Graham
    Bartlett, Nancy
    Wang, Jingyuan
    Brady, Kelly
    Sachs, Jessica
    Huebner, Dirk
    Hunder, Naomi N. H.
    Radford, John
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease:: 10-year results of a randomized trial
    le Maignan, C
    Desablens, B
    Delwail, V
    Dib, M
    Berthou, C
    Vigier, M
    Ghandour, C
    Atmani, S
    Casassus, P
    Maisonneuve, H
    Le Mevel, A
    Traullé, C
    Bernard, M
    Brière, J
    Colonna, P
    Andrieu, JM
    BLOOD, 2004, 103 (01) : 58 - 66
  • [23] Hodgkin Lymphoma and Female Fertility: A Multicenter Study of Fertility in Women Treated with Doxorubicin, Bleomycin, Vinblastine and Dacarbazine
    Machet, Antoine
    Tomowiak, Cecile
    Poudou, Caroline
    Levy, Anthony
    Sabirou, Florence
    Gruchet, Cecile
    Bobin, Arthur
    Moya, Niels
    Systchenko, Thomas
    Desmier, Deborah
    Noel, Stephanie
    Leleu, Xavier
    Delwail, Vincent
    Guidez, Stephanie
    BLOOD, 2017, 130
  • [24] TREATMENT OF ADVANCED HODGKIN DISEASE WITH ADRIAMYCIN, BLEOMYCIN, VINBLASTINE, AND IMIDAZOLE CARBOXAMIDE (ABVD) AFTER FAILURE OF MOPP THERAPY
    KRIKORIAN, JG
    PORTLOCK, CS
    ROSENBERG, SA
    CANCER, 1978, 41 (06) : 2107 - 2111
  • [25] TREATMENT OF MOPP-RESISTANT HODGKINS-DISEASE (HD) WITH ADRIAMYCIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE (ABVD)
    SANTORO, A
    MONFARDINI, S
    BONADONNA, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 363 - 363
  • [26] Benefits of BV-AVD (Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) versus ABVD (doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine) in patients with advanced-stage Hodgkin's lymphoma: an analysis of the ECHELON 1 trial by the GATLA group using the Delphi Method
    Pavlovsky, Astrid
    Altuve, Juan Ignacio Garcia
    Cerutti, Amalia
    Fiad, Lorena
    Kurgansky, Nicolas
    Warley, Fernando
    Aranguren, Florencia Negri
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S250 - S256
  • [27] Gonadal function following ABVD therapy for Hodgkin's disease
    Kulkarni, SS
    Sastry, PSRK
    Saikia, TK
    Parikh, PM
    Gopal, R
    Advani, SH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (04): : 354 - 357
  • [28] Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma
    Xicoy, Blanca
    Ribera, Josep-Maria
    Miralles, Pilar
    Berenguer, Juan
    Rubio, Rafael
    Mahillo, Beatriz
    Valencia, Maria-Eulalia
    Abella, Eugenia
    Lopez-Guillermo, Armando
    Sureda, Ana
    Morgades, Mireia
    Navarro, Jose-Tomas
    Esteban, Herminia
    Mate, J. L.
    Cosin, J.
    Lopez, J. C.
    Pulido, F.
    Moreno, V
    Cepeda, C.
    Gonzalez, J.
    Tellez, M. J.
    Vergas, J.
    Estrada, V
    Roca, V
    Montes, M. L.
    Arribas, J. R.
    Gonzalez-Garcia, J.
    Lacruz, J.
    Lopez, J.
    Salavert, M.
    Santos, J.
    Palacios, R.
    Marquez, M.
    Sepulveda, M. A.
    de la Torre, A.
    Rivero, A.
    Garcia, M.
    Pintado, V
    Antela, A.
    Patier, L.
    Rodriguez, L., I
    HAEMATOLOGICA, 2007, 92 (02) : 191 - 198
  • [29] Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease
    Friedberg, JW
    Neuberg, D
    Kim, H
    Miyata, S
    McCauley, M
    Fisher, DC
    Takvorian, T
    Canellos, GP
    CANCER, 2003, 98 (05) : 978 - 982
  • [30] A history of abvd (adriamycin/bleomycin/vinblastine/dacarbazine) therapy for hodgkin lymphoma alters the number of oocyte cryopreserved after in vitro maturation in candidates for urgent fertility preservation
    Grynberg, M.
    Le Parco, S.
    El Hachem, H.
    Sonigo, C.
    Sifer, C.
    Frydman, N.
    HUMAN REPRODUCTION, 2014, 29 : 238 - 239
12345